New USPSTF recommendations for screening for prediabetes and type 2 diabetes an opportunity to create national momentum
Gregg EW, Moin T
JAMA. 2021;326(8):701-703
Leggi
Screening for prediabetes and type 2 diabetes. US preventive services task force recommendation statement
Davidson KW, Barry MJ, Mangione CM, et al.
JAMA. 2021;326(8):736-743
Leggi
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
Sattar N, Lee MMY, Kristensen SL, et al.
The Lancet Diabetes & Endocrinology. Pub online 20 August 2021
Leggi
Empagliflozin in heart failure with a preserved ejection fraction
Anker SD, Butler J, Filippatos G, et al.
N Engl J Med. 27 August 2021
Leggi
Glucose-lowering therapy in patients with postpancreatitis diabetes mellitus: a nationwide population-based cohort study
Viggers R, Hasselstrøm Jensen M, Bering Laursen HV, et al.
Diabetes Care. 2021;44(9):2045-52
Leggi
Consensus report: definition and interpretation of remission in type 2 diabetes.
Riddle MC, Cefalu WT, Evans PH, et al.
Diabetologia. Pub. online 30 August 2021
Leggi
Once‐weekly subcutaneous semaglutide treatment for persons with type 2 diabetes: Real‐world data from a diabetes out‐patient clinic
Hansen KB, Svendstrup M, Lund A, et al.
Diabet Med. Pub. online 4 August 2021
Leggi
Racial differences in all-cause mortality and future complications among people with diabetes: a systematic review and meta-analysis of data from more than 2.4 million individuals
Ezzatvar Y, Ramírez-Vélez R, Izquierdo M, et al.
Diabetologia. Pub. online 28 August 2021
Leggi
Long-term complications in youth¬onset type 2 diabetes – TODAY study group
Bjornstad P, Drews KL, Caprio S, et al.
N Engl J Med 2021;385:416-426.
Leggi
Racial, rural, and regional disparities in diabetes-related lower-extremity amputation rates, 2009–2017
Akinlotan MA, Primm K, Bolin JN, et al.
Diabetes Care. 2021;dc203135.
Leggi